On Vertex and CRISPR Therapeutics’ heels, bluebird submits sickle cell gene therapy to FDA
Bluebird bio said Monday morning it has submitted an application for its sickle cell therapy to the FDA for potential approval …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.